Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy Sells 1,088 Shares

Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,088 shares of the company’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $107.33, for a total transaction of $116,775.04. Following the completion of the transaction, the executive vice president now owns 27,688 shares in the company, valued at approximately $2,971,753.04. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Varian Medical Systems, Inc. (NYSE VAR) traded up 0.13% during trading on Friday, hitting $104.77. 37,865 shares of the stock traded hands. The stock has a market cap of $9.62 billion, a PE ratio of 34.49 and a beta of 0.58. Varian Medical Systems, Inc. has a 12 month low of $75.20 and a 12 month high of $107.87. The company has a 50-day moving average price of $102.10 and a 200-day moving average price of $97.84.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.09. The firm had revenue of $662.40 million during the quarter, compared to analyst estimates of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.00 EPS. Equities research analysts expect that Varian Medical Systems, Inc. will post $3.93 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://weekherald.com/2017/09/22/kolleen-t-kennedy-sells-1088-shares-of-varian-medical-systems-inc-var-stock.html.

Several institutional investors and hedge funds have recently made changes to their positions in VAR. Profund Advisors LLC lifted its holdings in shares of Varian Medical Systems by 14.4% in the 1st quarter. Profund Advisors LLC now owns 3,866 shares of the medical equipment provider’s stock worth $352,000 after acquiring an additional 487 shares during the last quarter. ProShare Advisors LLC lifted its holdings in shares of Varian Medical Systems by 1.2% in the 1st quarter. ProShare Advisors LLC now owns 9,396 shares of the medical equipment provider’s stock worth $856,000 after acquiring an additional 115 shares during the last quarter. First Mercantile Trust Co. lifted its holdings in shares of Varian Medical Systems by 2.3% in the 1st quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after acquiring an additional 25 shares during the last quarter. Daiwa Securities Group Inc. lifted its holdings in shares of Varian Medical Systems by 12.0% in the 1st quarter. Daiwa Securities Group Inc. now owns 2,800 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 300 shares during the last quarter. Finally, Suntrust Banks Inc. raised its holdings in Varian Medical Systems by 23.0% during the 1st quarter. Suntrust Banks Inc. now owns 9,983 shares of the medical equipment provider’s stock valued at $907,000 after buying an additional 1,864 shares during the last quarter. Hedge funds and other institutional investors own 99.28% of the company’s stock.

A number of analysts have recently weighed in on VAR shares. BidaskClub downgraded shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Thursday, June 29th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 price target on shares of Varian Medical Systems in a report on Friday, September 1st. BTIG Research downgraded shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a report on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price target on shares of Varian Medical Systems in a report on Monday, August 28th. Finally, Zacks Investment Research raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating and set a $117.00 price objective for the company in a research note on Tuesday, June 27th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $97.39.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply